LeadIQ logo
Learn more at LeadIQ.com

Insights

Acquisition Opportunities NBE Therapeutics has been recently acquired by prominent pharmaceutical companies such as Boehringer Ingelheim and Gilead Sciences. This signals a strong validation of NBE's technology and product pipeline, creating potential opportunities for cross-selling and collaboration with the acquiring entities.

Partnership Potential NBE Therapeutics has established partnerships with companies like Legochembio and Boehringer Ingelheim. Leveraging these existing relationships can open doors for sales development representatives to explore collaborative projects and licensing agreements that can drive revenue growth.

Innovative Technology Stack NBE Therapeutics utilizes a tech stack including Google Analytics, Craft CMS, and Microsoft tools, showcasing a commitment to innovative solutions. Highlighting these technologies during sales pitches can position the company as cutting-edge, potentially attracting tech-savvy clients seeking advanced biotech solutions.

Expansion into Enzymatic Conjugation With the launch of an enzymatic conjugation platform, NBE Therapeutics has expanded its capabilities in ADC development. This new platform presents a unique selling point for sales teams, offering customers the advantage of efficient generation of ADCs with targeted toxin conjugation, potentially attracting clients seeking tailored drug solutions.

Strategic Market Positioning NBE Therapeutics operates in the biotechnology research industry and competes with companies like Aridis Pharmaceuticals and FairJourney Biologics. Analyzing the competitive landscape can provide valuable insights for sales professionals to identify market differentiators and effectively articulate the unique value proposition of NBE's oncology treatments to potential clients.

Similar companies to NBE-Therapeutics AG

NBE-Therapeutics AG Tech Stack

NBE-Therapeutics AG uses 8 technology products and services including Google Analytics, Craft CMS, Microsoft Excel, and more. Explore NBE-Therapeutics AG's tech stack below.

  • Google Analytics
    Analytics
  • Craft CMS
    Content Management System
  • Microsoft Excel
    Editors
  • Google Font API
    Font Scripts
  • Open Graph
    Miscellaneous
  • Microsoft
    Miscellaneous
  • Yii
    Web Frameworks
  • Nginx
    Web Servers

Media & News

NBE-Therapeutics AG's Email Address Formats

NBE-Therapeutics AG uses at least 1 format(s):
NBE-Therapeutics AG Email FormatsExamplePercentage
First.Last@nbe-therapeutics.comJohn.Doe@nbe-therapeutics.com
87%
LF@nbe-therapeutics.comDJ@nbe-therapeutics.com
4%
Fir.Last@nbe-therapeutics.comJoh.Doe@nbe-therapeutics.com
5%
First-Last@nbe-therapeutics.comJohn-Doe@nbe-therapeutics.com
4%

Frequently Asked Questions

Where is NBE-Therapeutics AG's headquarters located?

Minus sign iconPlus sign icon
NBE-Therapeutics AG's main headquarters is located at Hochbergstrasse 60C Technology Park Basel AG Basel, 4057 CH. The company has employees across 2 continents, including EuropeNorth America.

What is NBE-Therapeutics AG's official website and social media links?

Minus sign iconPlus sign icon
NBE-Therapeutics AG's official website is nbe-therapeutics.com and has social profiles on LinkedIn.

How much revenue does NBE-Therapeutics AG generate?

Minus sign iconPlus sign icon
As of September 2024, NBE-Therapeutics AG's annual revenue reached $3.8M.

What is NBE-Therapeutics AG's SIC code NAICS code?

Minus sign iconPlus sign icon
NBE-Therapeutics AG's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NBE-Therapeutics AG have currently?

Minus sign iconPlus sign icon
As of September 2024, NBE-Therapeutics AG has approximately 42 employees across 2 continents, including EuropeNorth America. Key team members include Chief Scientific Officer: C. D.Head Of Conjugation: H. B.Head Of In Vivo Unit: M. M.. Explore NBE-Therapeutics AG's employee directory with LeadIQ.

What industry does NBE-Therapeutics AG belong to?

Minus sign iconPlus sign icon
NBE-Therapeutics AG operates in the Biotechnology Research industry.

What technology does NBE-Therapeutics AG use?

Minus sign iconPlus sign icon
NBE-Therapeutics AG's tech stack includes Google AnalyticsCraft CMSMicrosoft ExcelGoogle Font APIOpen GraphMicrosoftYiiNginx.

What is NBE-Therapeutics AG's email format?

Minus sign iconPlus sign icon
NBE-Therapeutics AG's email format typically follows the pattern of . Find more NBE-Therapeutics AG email formats with LeadIQ.

How much funding has NBE-Therapeutics AG raised to date?

Minus sign iconPlus sign icon
As of September 2024, NBE-Therapeutics AG has raised $22M in funding. The last funding round occurred on Jan 10, 2020 for $22M.
NBE-Therapeutics AG

NBE-Therapeutics AG

Biotechnology ResearchBasel, Switzerland11-50 Employees

At NBE Therapeutics we strive to develop best-in-class oncology treatments to increase survival and improve quality of life for cancer patients worldwide. Through our highly innovative novel in-house developed technologies, we have created a next generation antibody drug conjugate platform targeting solid tumors.

Our platform allows us to develop targeted medicines, that through a long-lasting immune oncology effect, could reduce or even eradicate tumors. Our dedicated international team has been able to create a pipeline of ADC product candidates in various stages of development to enter clinical phases to create better treatments for cancer patients in need of more selective drugs.

Section iconCompany Overview

Headquarters
Hochbergstrasse 60C Technology Park Basel AG Basel, 4057 CH
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $22M

    NBE-Therapeutics AG has raised a total of $22M of funding over 5 rounds. Their latest funding round was raised on Jan 10, 2020 in the amount of $22M.

  • $10M

    NBE-Therapeutics AG's revenue is in the range of $10M

Section iconFunding & Financials

  • $22M

    NBE-Therapeutics AG has raised a total of $22M of funding over 5 rounds. Their latest funding round was raised on Jan 10, 2020 in the amount of $22M.

  • $10M

    NBE-Therapeutics AG's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.